Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial
Edward E. Partridge(University of Alabama at Birmingham), Saundra S. Buys(University of Utah), Robert T. Greenlee(Marshfield Clinic), Aimée R. Kreimer(National Cancer Institute), Craig Williams(The University of Adelaide), Timothy R. Church(University of Minnesota), Christine Cole Johnson(Henry Ford Health System), Joel L. Weissfeld(University of Pittsburgh), Claudine Isaacs(Georgetown University), Lawrence R. Ragard(Westat (United States)), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Sheryl Ogden(University of Alabama at Birmingham), Jian-Lun Xu(National Institutes of Health), Bruce Kessel(University of Hawaiʻi at Mānoa)
Cited by 258
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
|Nature Genetics|2007|1.5k
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
|New England Journal of Medicine|2000|1.4k